This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

7 Aug 2013

Gammagard IVIg mechanisms investigated

The drug may prevent inflammation in the brain and hence inhibit plaque build-up.


Researchers have conducted an investigation in order to further understanding of the mechanisms behind the Alzheimer's disease treatment Gammagard IVIg.

Related News